Posts by Christolyn Rajakulenthiran

Vitreomacular traction

There has been some recent discussion around Ocriplasmin – trade name Jetrea- a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface. It is used for treatment of symptomatic vitreomacular adhesion, via intravitreal injection, for which it has recently been approved for use in Australia. Sometimes controversial as a single treatment…

Read More

an atypical retinal appearance

This is a case that an optometrist recently sent me . A middle aged man , no apparent change in vision but an unusual pigmentation/ depigmenation to the retina. Focus on the pale subretinal lesions. A similar appearance in the fellow eye ( not shown). A case of birdshot chorioretinoapthy -at present inactive.

Read More

A challenging case..

This 10year yo otherwise well boy presented with what appeared to be optic nerve swelling in both eyes. A work up for papilloedema including neuro-imaging , infective screening , lumbar puncture and opening CSF pressure was done showing no anomalies. Without active treatment vision is returning and the disc and retinal oedema appears to be…

Read More

It pays to further investigate…

To a retinal specialist, the importance of a fundus fluorescein angiogram (FFA) as a follow up investigation is commonplace. What isn’t so routine is expecting to find something that you weren’t quote convinced was present on examination of a patient’s retinal fundus. I share the following post with you as I was somewhat surprised by…

Read More

ANZRS meeting

This annual meeting of retinal specialists nation wide gave us the opportunity to share our experiences and knowledge about current treatments for retinal disease as well as discuss upcoming research. Among the hot topics discussed were the recent trials arguing for intra-vitreal injections over retinal laser for treatment of proliferative diabetic retinopathy. There have recently…

Read More

Conference News..

The annual Hawaiian Eye Conference looked at  the new developments in optical coherence tomography (OCT) technology, including angiography, swept source, wide-field and en face OCT. current trends in pharmacotherapy for neovascular age-related macular degeneration (AMD), including diagnostic evaluation, agent choice and various dosing regimens.  the new and investigational treatment schemes for wet AMD, including the…

Read More

New Journal Studies AAO

  Mediterranean diet may protect against late AMD Investigators examined a year’s worth of dietary data on 4,753 people from 7 European countries. Using the previously published Mediterranean Diet Score (MDS), the authors showed that participants in the highest MDS category had a 20% reduced risk of developing late AMD (P=0.05). No link emerged between…

Read More

Euretina conference : the treat and extend protocol in AMD

      Most patients in the maintenance phase of a treat-and-extend regimen for AMD continue to require treatment approximately every 8 weeks, according to this analysis of data from a large international voluntary registry of neovascular AMD. While there is little debate about the best approach to the induction phase of a treatment treat-and-extend…

Read More